Prajna Lalitha1. 1. Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, No.1 Anna Nagar, Madurai, Tamil Nadu 625020, India. lalitha@aravind.org
Abstract
PURPOSE OF REVIEW: Nocardia keratitis is a rarity in most parts of the world. If the diagnosis is timely, and appropriate treatment started, then the visual outcome is good. The purpose of this review is to discuss the recently published literature in relation to the epidemiology, cause, diagnosis, and therapy of Nocardia keratitis. RECENT FINDINGS: The incidence of Nocardia keratitis, although not well established, appears to be increasing with new species identified with newer molecular methods. The different species causing keratitis are Nocardia. arthritidis, N. neocaledoniensis, N. asiatica, N. asteroids type IV, N. brasiliensis, N. pseudobrasiliensis, N. cyriacigeorgica, N. farcinica, N. otitidiscaviarum, and N. transvalensis. Current therapies with fortified amikacin and newer fluoroquinolones are effective, provided the diagnosis has been made in good time. Ongoing research toward rapid diagnosis using various molecular techniques seems to be promising. Diagnostic microbiology laboratories need to be familiar with these organisms especially in endemic areas, and it is important for the clinician to notify the suspicion of such cases. SUMMARY: The current recommended treatment is amikacin, and with appropriate therapy, Nocardia keratitis resolves with scarring, with or without vascularization, resulting in good visual outcome.
PURPOSE OF REVIEW: Nocardia keratitis is a rarity in most parts of the world. If the diagnosis is timely, and appropriate treatment started, then the visual outcome is good. The purpose of this review is to discuss the recently published literature in relation to the epidemiology, cause, diagnosis, and therapy of Nocardia keratitis. RECENT FINDINGS: The incidence of Nocardia keratitis, although not well established, appears to be increasing with new species identified with newer molecular methods. The different species causing keratitis are Nocardia. arthritidis, N. neocaledoniensis, N. asiatica, N. asteroids type IV, N. brasiliensis, N. pseudobrasiliensis, N. cyriacigeorgica, N. farcinica, N. otitidiscaviarum, and N. transvalensis. Current therapies with fortified amikacin and newer fluoroquinolones are effective, provided the diagnosis has been made in good time. Ongoing research toward rapid diagnosis using various molecular techniques seems to be promising. Diagnostic microbiology laboratories need to be familiar with these organisms especially in endemic areas, and it is important for the clinician to notify the suspicion of such cases. SUMMARY: The current recommended treatment is amikacin, and with appropriate therapy, Nocardia keratitis resolves with scarring, with or without vascularization, resulting in good visual outcome.
Authors: W L Liu; C C Lai; W C Ko; Y H Chen; H J Tang; Y L Huang; Y T Huang; P R Hsueh Journal: Eur J Clin Microbiol Infect Dis Date: 2011-04-03 Impact factor: 3.267
Authors: Saad J Taj-Aldeen; Anand Deshmukh; Sanjay Doiphode; Atqah Abdul Wahab; Mona Allangawi; Ahmed Almuzrkchi; Corné H Klaassen; Jacques F Meis Journal: Can J Infect Dis Med Microbiol Date: 2013 Impact factor: 2.471
Authors: Prajna Lalitha; Muthiah Srinivasan; Revathi Rajaraman; Meenakshi Ravindran; Jeena Mascarenhas; Jeganathan Lakshmi Priya; Aileen Sy; Catherine E Oldenburg; Kathryn J Ray; Michael E Zegans; Stephen D McLeod; Thomas M Lietman; Nisha R Acharya Journal: Am J Ophthalmol Date: 2012-09-05 Impact factor: 5.258
Authors: Anthony Zoropogui; Petar Pujic; Philippe Normand; Valérie Barbe; Patrick Belli; Arnault Graindorge; David Roche; David Vallenet; Sophie Mangenot; Patrick Boiron; Véronica Rodriguez-Nava; Sebastien Ribun; Yves Richard; Benoit Cournoyer; Didier Blaha Journal: BMC Genomics Date: 2013-04-27 Impact factor: 3.969